Peregrine Capital Management’s Privia Health PRVA Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $7.9M | Buy |
343,292
+13,162
| +4% | +$303K | 0.24% | 122 |
|
2025
Q1 | $7.41M | Buy |
330,130
+9,362
| +3% | +$210K | 0.25% | 116 |
|
2024
Q4 | $6.27M | Buy |
320,768
+5,759
| +2% | +$113K | 0.19% | 166 |
|
2024
Q3 | $5.74M | Buy |
315,009
+819
| +0.3% | +$14.9K | 0.17% | 191 |
|
2024
Q2 | $5.46M | Buy |
314,190
+32,311
| +11% | +$562K | 0.16% | 218 |
|
2024
Q1 | $5.52M | Buy |
281,879
+58,640
| +26% | +$1.15M | 0.16% | 222 |
|
2023
Q4 | $5.14M | Sell |
223,239
-66,975
| -23% | -$1.54M | 0.15% | 226 |
|
2023
Q3 | $6.67M | Buy |
290,214
+35,948
| +14% | +$827K | 0.2% | 205 |
|
2023
Q2 | $6.64M | Buy |
254,266
+68
| +0% | +$1.78K | 0.18% | 224 |
|
2023
Q1 | $7.02M | Sell |
254,198
-20,269
| -7% | -$560K | 0.2% | 215 |
|
2022
Q4 | $6.23M | Buy |
274,467
+63,942
| +30% | +$1.45M | 0.2% | 221 |
|
2022
Q3 | $7.17M | Sell |
210,525
-63,191
| -23% | -$2.15M | 0.23% | 201 |
|
2022
Q2 | $7.97M | Sell |
273,716
-30,839
| -10% | -$898K | 0.24% | 186 |
|
2022
Q1 | $8.14M | Sell |
304,555
-22,457
| -7% | -$600K | 0.19% | 213 |
|
2021
Q4 | $8.46M | Buy |
327,012
+9,416
| +3% | +$244K | 0.17% | 224 |
|
2021
Q3 | $7.48M | Buy |
317,596
+11,392
| +4% | +$268K | 0.16% | 233 |
|
2021
Q2 | $13.6M | Buy |
+306,204
| New | +$13.6M | 0.24% | 190 |
|